Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
5,073 studies for “Novartis”
Sponsor: Novartis Pharmaceuticals
Steroid-refractory Acute Graft Versus Host Disease
China
- A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis SuppurativaActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Hidradenitis Suppurativa
United States, Argentina, Austria, Belgium, Canada +14 more
- An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Metastatic Hormone-sensitive Prostate Cancer
United States, Australia, Brazil, Canada, China +10 more
Sponsor: Novartis Pharmaceuticals
Primary Myelofibrosis (PMF) · Post-polycythemia Vera Myelofibrosis (PPV-MF) · Post-essential Thrombocythemia Myelofibrosis (PET-MF)
United States, Argentina, Australia, China, India +4 more
- A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed SteroidsActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Primary Immune Thrombocytopenia
United States, Argentina, Austria, Belgium, China +19 more
Sponsor: Novartis Pharmaceuticals
Tuberous Sclerosis Complex
United States, Australia, Belgium, Canada, Colombia +13 more
- Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung CancerActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Non-Small Cell Lung Cancer
United States, Argentina, Australia, Canada, China +20 more
Sponsor: Novartis Pharmaceuticals
Early Breast Cancer
United States, Argentina, Australia, Brazil, Canada +11 more
Sponsor: Novartis Pharmaceuticals
Progressive Metastatic Castrate Resistant Prostate Cancer
United States, Australia, Canada, China, Denmark +9 more
- Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALLActive Not Recruiting
Sponsor: Dana-Farber Cancer Institute
Acute Lymphoblastic Leukemia ALL
United States
- Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus NephritisActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Lupus Nephritis
United States, Argentina, Brazil, Canada, Chile +22 more
Sponsor: Novartis Pharmaceuticals
Hidradenitis Suppurativa
United States, Argentina, Australia, Austria, Belgium +33 more
- Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Systemic Lupus Erythematosus
United States, Argentina, Australia, Chile, Colombia +10 more
- A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved RemissionActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Non-radiographic Axial Spondyloarthritis
Belgium, Brazil, Colombia, Czechia, France +13 more
- Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Polymyalgia Rheumatica
United States, Argentina, Australia, Belgium, Brazil +17 more
- An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus ErythematosusActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Systemic Lupus Erythematosus · Lupus Nephritis
Australia, France, Germany, Spain, Switzerland
- Pediatric Long-Term Follow-up and Rollover StudyActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Diffuse Astrocytoma · Anaplastic Astrocytoma · Astrocytoma · Oligodendroglioma, Childhood
United States, Argentina, Australia, Belgium, Brazil +14 more
Sponsor: Novartis Pharmaceuticals
Juvenile Psoriatic Arthritis
United States
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
United States
Sponsor: Novartis Pharmaceuticals
Plaque Psoriasis · Psoriatic Arthritis
Canada
Sponsor: Novartis Pharmaceuticals
Primary Immune Thrombocytopenia (ITP) · Primary Evans Syndrome (ES)
United States
- Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Systemic Lupus Erythematosus
United States, Argentina, Brazil, Bulgaria, Canada +14 more
Sponsor: Novartis Pharmaceuticals
Breast Cancer
Belgium, Bulgaria, Canada, Czechia, Denmark +12 more
- [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast CancerActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Breast Cancer
United States, China, France, Germany, Poland +2 more
- A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in KuwaitNot Yet Recruiting
Sponsor: Novartis Pharmaceuticals
Leukemia, Myeloid, Chronic-Phase
5,073 studies found